Everest Organics

31
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE334C01029
  • NSEID:
  • BSEID: 524790
INR
273.20
-1.65 (-0.6%)
BSENSE

Jun 24, 03:30 PM

BSE+NSE Vol: 377

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -19.15% vs 7.75% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -34.26% vs 1,081.61% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -5.06% vs 65.18% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -1,026.94% vs 176.40% in Mar 2024

Compare Profit and Loss Results of Everest Organics
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
182.00
43.00
139.00
323.26%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
22.00
0.00
22.00
0%
Net Sales
159.00
43.00
116.00
269.77%
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
0.00
1.00
0%
Raw Materials Consumed
97.00
0.00
97.00
0%
Power & Fuel Cost
14.00
2.00
12.00
600.00%
Employee Cost
16.00
12.00
4.00
33.33%
Operating Expenses
11.00
9.00
2.00
22.22%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
0.00
4.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
0.00
1.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
152.00
28.00
124.00
442.86%
Operating Profit (PBDIT) excl Other Income
7.00
14.00
-7.00
-50.00%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
7.00
15.00
-8.00
-53.33%
Interest
5.00
0.00
5.00
0%
Profit before Depriciation and Tax
2.00
15.00
-13.00
-86.67%
Depreciation
5.00
6.00
-1.00
-16.67%
Profit Before Taxation & Exceptional Items
-3.00
8.00
-11.00
-137.50%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-3.00
10.00
-13.00
-130.00%
Provision for Tax
-1.00
5.00
-6.00
-120.00%
Profit After Tax
-1.00
5.00
-6.00
-120.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
34.00
-180.00
214.00
118.89%
Profit Available for appropriations
32.00
-174.00
206.00
118.39%
Appropriations
32.00
-174.00
206.00
118.39%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-2.97
0.92
-3.89
-422.83%
Profit And Loss - Net Sales
Net Sales 159.48 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -19.15% vs 7.75% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.22 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -34.26% vs 1,081.61% in Mar 2024

Profit And Loss - Interest
Interest 5.19 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.06% vs 65.18% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -1.29 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -1,026.94% vs 176.40% in Mar 2024